BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 32981180)

  • 1. A cross-section of UK prostate cancer diagnostics during the coronavirus disease 2019 (COVID-19) era - a shifting paradigm?
    Stroman L; Cathcart P; Lamb A; Challacombe B; Popert R
    BJU Int; 2021 Jan; 127(1):30-34. PubMed ID: 32981180
    [No Abstract]   [Full Text] [Related]  

  • 2. Management of patients who opt for radical prostatectomy during the coronavirus disease 2019 (COVID-19) pandemic: an international accelerated consensus statement.
    Tandogdu Z; Collins J; Shaw G; Rohn J; Koves B; Sachdeva A; Ghazi A; Haese A; Mottrie A; Kumar A; Sivaraman A; Tewari A; Challacombe B; Rocco B; Giedelman C; Wagner C; Rogers CG; Murphy DG; Pushkar D; Ogaya-Pinies G; Porter J; Seetharam KR; Graefen M; Orvieto MA; Moschovas MC; Schatloff O; Wiklund P; Coelho R; Valero R; de Reijke TM; Ahlering T; Rogers T; van der Poel HG; Patel V; Artibani W; Wagenlehner F; Maes K; Rha KH; Nathan S; Bjerklund Johansen TE; Hawkey P; Kelly J
    BJU Int; 2021 Jun; 127(6):729-741. PubMed ID: 33185026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of androgen deprivation therapy on the severity of COVID-19 in prostate cancer patients.
    Jiménez-Alcaide E; García-Fuentes C; Hernández V; De la Peña E; Pérez-Fernández E; Castro A; Caballero-Perea B; Guijarro A; Llorente C
    Prostate; 2021 Dec; 81(16):1349-1354. PubMed ID: 34517429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Our first month of delivering the prostate cancer diagnostic pathway within the limitations of COVID-19 using local anaesthesia transperineal biopsy.
    Popert R; Kum F; MacAskill F; Stroman L; Zisengwe G; Rusere J; Haire K; Challacombe B; Cathcart P
    BJU Int; 2020 Sep; 126(3):329-332. PubMed ID: 32455471
    [No Abstract]   [Full Text] [Related]  

  • 5. Prostate cancer upgrading with serial prostate magnetic resonance imaging and repeat biopsy in men on active surveillance: are confirmatory biopsies still necessary?
    Osses DF; Drost FH; Verbeek JFM; Luiting HB; van Leenders GJLH; Bangma CH; Krestin GP; Roobol MJ; Schoots IG
    BJU Int; 2020 Jul; 126(1):124-132. PubMed ID: 32232921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of metastatic disease on
    Yaxley JW; Raveenthiran S; Nouhaud FX; Samaratunga H; Yaxley WJ; Coughlin G; Yaxley AJ; Gianduzzo T; Kua B; McEwan L; Wong D
    BJU Int; 2019 Sep; 124(3):401-407. PubMed ID: 31141284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical diagnosis and staging of prostatic carcinoma.
    Alcini E; D'Addessi A
    Rays; 1993; 18(1):3-13. PubMed ID: 7689236
    [No Abstract]   [Full Text] [Related]  

  • 8. The effect of delaying transperineal fusion biopsy of the prostate for patients with suspicious MRI findings-Implications for the COVID-19 era.
    Savin Z; Dekalo S; Marom R; Barnes S; Gitstein G; Mabjeesh NJ; Matzkin H; Yossepowitch O; Keren-Paz G; Mano R
    Urol Oncol; 2021 Jan; 39(1):73.e1-73.e8. PubMed ID: 32778478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impacts of the COVID-19 pandemic on early detection of prostate cancer in Australia.
    Ip CCK; Kealey J; Davis ID; Sengupta S
    BJU Int; 2021 Dec; 128 Suppl 3(Suppl 3):6-8. PubMed ID: 34750958
    [No Abstract]   [Full Text] [Related]  

  • 10. Diagnosis and treatment of patients with prostate cancer: the nurse's role.
    Turner B
    Nurs Stand; 2007 Jun 6-12; 21(39):48-56; quiz 58. PubMed ID: 17569378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Androgen-deprivation therapies for prostate cancer and risk of infection by SARS-CoV-2: a population-based study (N = 4532).
    Montopoli M; Zumerle S; Vettor R; Rugge M; Zorzi M; Catapano CV; Carbone GM; Cavalli A; Pagano F; Ragazzi E; Prayer-Galetti T; Alimonti A
    Ann Oncol; 2020 Aug; 31(8):1040-1045. PubMed ID: 32387456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 'Case of the Month' from the National Cancer Institute, Bethesda, MD, USA: investigating genetic aberrations in a patient with high-risk prostate cancer.
    O'Connor LP; Lebastchi AH; Fasaye GA; Dikoglu E; Daneshvar MA; Ahdoot M; Merino MJ; Pinto PA
    BJU Int; 2021 Feb; 127(2):171-174. PubMed ID: 33547722
    [No Abstract]   [Full Text] [Related]  

  • 13. Individual prognosis at diagnosis in nonmetastatic prostate cancer: Development and external validation of the PREDICT Prostate multivariable model.
    Thurtle DR; Greenberg DC; Lee LS; Huang HH; Pharoah PD; Gnanapragasam VJ
    PLoS Med; 2019 Mar; 16(3):e1002758. PubMed ID: 30860997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How can we expand active surveillance criteria in patients with low- and intermediate-risk prostate cancer without increasing the risk of misclassification? Development of a novel risk calculator.
    Gandaglia G; van den Bergh RCN; Tilki D; Fossati N; Ost P; Surcel CI; Sooriakumaran P; Tsaur I; Valerio M; Kretschmer A; Zaffuto E; Salomon L; Montorsi F; Graefen M; van der Poel H; de la Taille A; Briganti A; Ploussard G;
    BJU Int; 2018 Nov; 122(5):823-830. PubMed ID: 29772103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostate cancer screening and the management of clinically localized disease.
    Wilt TJ; Ahmed HU
    BMJ; 2013 Jan; 346():f325. PubMed ID: 23360718
    [No Abstract]   [Full Text] [Related]  

  • 16. Impact of the COVID-19 pandemic on the diagnosis and treatment of men with prostate cancer.
    Nossiter J; Morris M; Parry MG; Sujenthiran A; Cathcart P; van der Meulen J; Aggarwal A; Payne H; Clarke NW
    BJU Int; 2022 Aug; 130(2):262-270. PubMed ID: 35080142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recommendations for prostate cancer diagnosis and treatment during COVID-19 outbreak were not followed in Brazil.
    Korkes F; Smaidi K; Timoteo F; Glina S
    Int Braz J Urol; 2022; 48(4):712-718. PubMed ID: 35195387
    [No Abstract]   [Full Text] [Related]  

  • 18. Screening for early prostate cancer: what is the problem?
    Moffat L
    J R Coll Surg Edinb; 2000 Apr; 45(2):127-31. PubMed ID: 10822923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The pathologist's role: to diagnose prostatic cancer and determine prognosis].
    Egevad L
    Lakartidningen; 2012 Feb 22-28; 109(8):403-6. PubMed ID: 22509665
    [No Abstract]   [Full Text] [Related]  

  • 20. Is there still a role for digital rectal examination in the prostate cancer diagnostic pathway in the COVID-19 and post COVID-19 era?
    Tan WS; Wong A; Mahmalji W; Raza A
    Aging Male; 2021 Dec; 24(1):92-94. PubMed ID: 34319201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.